Ryan Spencer - 10 Feb 2026 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Feb 2026, 16:15:33 UTC
Prior SEC filing
07 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Ryan R. Spencer, by /s/ Trevor Dutcher, Attorney-in-fact

Key filing fact

Ryan Spencer filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 10 Feb 2026.

Key facts

  • This page summarizes Ryan Spencer's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
  • 15 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 07 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001777938 Primary reporting owner

Spencer Ryan

Relationship
CEO and Director, Director
Address
C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE
Signature
Ryan R. Spencer, by /s/ Trevor Dutcher, Attorney-in-fact
Signature date
10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DVAX transaction

Common Stock

Disposition pursuant to a tender of shares in a change of control transaction

Transaction value
Shares
-379,620
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Footnotes
F1, F2, F3
DVAX transaction

Common Stock - Performance Stock Units

Award

Transaction value
Shares
+165,000
Change %
Price
Shares after
165,000
Date
10 Feb 2026
Ownership
Direct
Footnotes
F4
DVAX transaction

Common Stock - Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-165,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Footnotes
F1, F2, F5
DVAX transaction

Common Stock - Performance Stock Units

Award

Transaction value
Shares
+136,000
Change %
Price
Shares after
136,000
Date
10 Feb 2026
Ownership
Direct
Footnotes
F6
DVAX transaction

Common Stock - Performance Stock Units

Disposed to Issuer

Transaction value
Shares
-136,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Footnotes
F1, F2, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-50,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
50,000
Exercise price
$3.81
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-400,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
400,000
Exercise price
$6.80
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-130,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
130,000
Exercise price
$5.22
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-250,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250,000
Exercise price
$9.59
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-350,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350,000
Exercise price
$12.74
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-280,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
280,000
Exercise price
$11.12
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-231,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
231,000
Exercise price
$12.48
Footnotes
F1, F2, F7
DVAX transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-225,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
225,000
Exercise price
$12.69
Footnotes
F1, F2, F7, F8
DVAX transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-55,000
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
Footnotes
F1, F2, F9, F10
DVAX transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-90,667
Change %
-100%
Price
Shares after
0
Date
10 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
90,667
Exercise price
Footnotes
F1, F2, F10, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ryan Spencer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 11 footnotes

Footnote F1

This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, SANOFI, a French societe anonyme ("Parent"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Purchaser").

Footnote F2

Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the "Common Stock"), for $15.50 per share (the "Offer Price"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the "Effective Time").

Footnote F3

Pursuant to the terms of the Merger Agreement, at the Effective Time, each share of Common Stock held by the Reporting Person was tendered in exchange for the Offer Price.

Footnote F4

Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person in 2024, which vest based on how the Issuer's total stockholder return compares to the total stockholder return of an indexed group of companies ("rTSR") over a performance period ending on December 31, 2026.

Footnote F5

Pursuant to the terms of the Merger Agreement, at the Effective Time, each PSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such PSU award immediately prior to the Effective Time based on attainment of the performance goal at 150% of the target level, without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any PSU award that was granted in calendar year 2025, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Footnote F6

Represents PSUs previously granted to the Reporting Person in 2025, which vest based on rTSR over a performance period ending on December 31, 2027.

Footnote F7

Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time (other than a stock option granted in calendar year 2025 became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option, except that in the case of any portion of a stock option granted in calendar year 2025 that remained unvested as of the immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Footnote F8

The stock option was granted to the Reporting Person in 2025.

Footnote F9

The restricted stock units ("RSUs") were granted on February 15, 2024, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 15, 2024.

Footnote F10

Pursuant to the terms of the Merger Agreement, at the Effective Time, each RSU award that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price, except that in the case of any portion of an RSU award granted in calendar year 2025 that remained unvested as of immediately prior to the Effective Time, 50% of such cash amount is subject to vesting requirements and scheduled to vest 6 months after the Effective Time, as described in the Merger Agreement.

Footnote F11

The RSUs were granted on February 13, 2025, and were originally scheduled to vest over three years, with 1/3 vesting on each anniversary of February 13, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .